A novel monoallelic gain of function mutation in p110δ causing atypical activated phosphoinositide 3-kinase δ syndrome (APDS-1).
APDS-1
B cells
Bone marrow
Hypogammaglobulinemia
T cells
p110δ
Journal
Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
16
11
2018
revised:
03
01
2019
accepted:
08
01
2019
pubmed:
15
1
2019
medline:
1
1
2020
entrez:
15
1
2019
Statut:
ppublish
Résumé
This study reports on a novel activating p110δ mutation causing adult-onset hypogammaglobulinemia with lymphopenia without the classical presentation of atypical Activated phosphoinositide 3-kinase δ syndrome (ADPS-1), underlining thus the heterogeneous clinical and immunological presentation of p110δ mutated individuals and offers additional data on the role of p110δ in early and late B cell development in humans.
Identifiants
pubmed: 30639166
pii: S1521-6616(18)30664-8
doi: 10.1016/j.clim.2019.01.003
pii:
doi:
Substances chimiques
Class I Phosphatidylinositol 3-Kinases
EC 2.7.1.137
PIK3CD protein, human
EC 2.7.1.137
Types de publication
Case Reports
Letter
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
31-34Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.